Genetic Screening of Greek Patients with Huntington’s Disease Phenocopies Identifies an SCA8 Expansion

Overview

Journal J Neurol

Specialty Neurology

Date 2012 Feb 3

PMID 22297462

Citations 9

Authors

G Koutsis

G Karadima

A Pandraud

M G Sweeney

R Paudel

H Houlden

N W Wood

M Panas

Affiliations

Soon will be listed here.

Abstract

Huntington’s disease (HD) is an autosomal dominant disorder characterized by a triad of chorea, psychiatric disturbance and cognitive decline. Around 1% of patients with HD-like symptoms lack the causative HD expansion and are considered HD phenocopies. Genetic diseases that can present as HD phenocopies include HD-like syndromes such as HDL1, HDL2 and HDL4 (SCA17), some spinocerebellar ataxias (SCAs) and dentatorubral-pallidoluysian atrophy (DRPLA). In this study we screened a cohort of 21 Greek patients with HD phenocopy syndromes formutations causing HDL2, SCA17, SCA1, SCA2, SCA3,SCA8, SCA12 and DRPLA. Fifteen patients (71%) had a positive family history. We identified one patient (4.8% of the total cohort) with an expansion of 81 combined CTA/CTG repeats at the SCA8 locus. This falls within what is believed to be the high-penetrance allele range. In addition to the classic HD triad, the patient had features of dystonia and oculomotor apraxia. There were no cases of HDL2, SCA17, SCA1, SCA2, SCA3, SCA12 or DRPLA. Given the controversy surrounding the SCA8 expansion, the present finding may be incidental. However, if pathogenic, it broadens the phenotype that may be associated with SCA8 expansions. The absence of any other mutations in our cohort is not surprising, given the low probability of reaching a genetic diagnosis in HD phenocopy patients.

Citing Articles

Short tandem repeat expansions in sporadic amyotrophic lateral sclerosis and frontotemporal dementia.

Henden L, Fearnley L, Grima N, McCann E, Dobson-Stone C, Fitzpatrick L Sci Adv. 2023; 9(18):eade2044.

PMID: 37146135 PMC: 10162670. DOI: 10.1126/sciadv.ade2044.

Profiling human pathogenic repeat expansion regions by synergistic and multi-level impacts on molecular connections.

Fan C, Chen K, Wang Y, Ball E, Stenson P, Mort M Hum Genet. 2022; 142(2):245-274.

PMID: 36344696 PMC: 10290229. DOI: 10.1007/s00439-022-02500-6.

Combining Literature Review With a Ground Truth Approach for Diagnosing Huntington's Disease Phenocopy.

Nguyen Q, Ortigoza Escobar J, Burgunder J, Mariotti C, Saft C, Elisabeth Hjermind L Front Neurol. 2022; 13:817753.

PMID: 35222250 PMC: 8866848. DOI: 10.3389/fneur.2022.817753.

CCG•CGG interruptions in high-penetrance SCA8 families increase RAN translation and protein toxicity.

Perez B, Shorrock H, Banez-Coronel M, Zu T, Romano L, Laboissonniere L EMBO Mol Med. 2021; 13(11):e14095.

PMID: 34632710 PMC: 8573593. DOI: 10.15252/emmm.202114095.

Huntington's Disease, Huntington's Disease Look-Alikes‎, and Benign Hereditary Chorea: What's New?.

Schneider S, Bird T Mov Disord Clin Pract. 2019; 3(4):342-354.

PMID: 30713928 PMC: 6353394. DOI: 10.1002/mdc3.12312.

References

Gupta A, Jankovic J . Spinocerebellar ataxia 8: variable phenotype and unique pathogenesis. Parkinsonism Relat Disord. 2009; 15(9):621-6. DOI: 10.1016/j.parkreldis.2009.06.001. View

Ito H, Kawakami H, Wate R, Matsumoto S, Imai T, Hirano A . Clinicopathologic investigation of a family with expanded SCA8 CTA/CTG repeats. Neurology. 2006; 67(8):1479-81. DOI: 10.1212/01.wnl.0000240256.13633.7b. View

Schneider S, Walker R, Bhatia K . The Huntington's disease-like syndromes: what to consider in patients with a negative Huntington's disease gene test. Nat Clin Pract Neurol. 2007; 3(9):517-25. DOI: 10.1038/ncpneuro0606. View

Daughters R, Tuttle D, Gao W, Ikeda Y, Moseley M, Ebner T . RNA gain-of-function in spinocerebellar ataxia type 8. PLoS Genet. 2009; 5(8):e1000600. PMC: 2719092. DOI: 10.1371/journal.pgen.1000600. View

Squitieri F, Berardelli A, Nargi E, Castellotti B, Mariotti C, Cannella M . Atypical movement disorders in the early stages of Huntington's disease: clinical and genetic analysis. Clin Genet. 2000; 58(1):50-6. DOI: 10.1034/j.1399-0004.2000.580108.x. View

Sulek-Piatkowska A, Krysa W, Zdzienicka E, Szirkowiec W, Hoffman-Zacharska D, Rajkiewicz M . Searching for mutation in the JPH3, ATN1 and TBP genes in Polish patients suspected of Huntington's disease and without mutation in the IT15 gene. Neurol Neurochir Pol. 2008; 42(3):203-9. View

Wild E, Mudanohwo E, Sweeney M, Schneider S, Beck J, Bhatia K . Huntington's disease phenocopies are clinically and genetically heterogeneous. Mov Disord. 2008; 23(5):716-20. DOI: 10.1002/mds.21915. View

Stevanin G, Herman A, Durr A, Jodice C, Frontali M, Agid Y . Are (CTG)n expansions at the SCA8 locus rare polymorphisms?. Nat Genet. 2000; 24(3):213; author reply 215. DOI: 10.1038/73408. View

Ikeda Y, Dalton J, Moseley M, Gardner K, Bird T, Ashizawa T . Spinocerebellar ataxia type 8: molecular genetic comparisons and haplotype analysis of 37 families with ataxia. Am J Hum Genet. 2004; 75(1):3-16. PMC: 1182005. DOI: 10.1086/422014. View

10.

Panas M, Karadima G, Vassos E, Kalfakis N, Kladi A, Christodoulou K . Huntington's disease in Greece: the experience of 14 years. Clin Genet. 2010; 80(6):586-90. DOI: 10.1111/j.1399-0004.2010.01603.x. View

11.

Stevanin G, Fujigasaki H, Lebre A, Camuzat A, Jeannequin C, Dode C . Huntington's disease-like phenotype due to trinucleotide repeat expansions in the TBP and JPH3 genes. Brain. 2003; 126(Pt 7):1599-603. DOI: 10.1093/brain/awg155. View

12.

Kremer B, Goldberg P, Andrew S, Theilmann J, Telenius H, Zeisler J . A worldwide study of the Huntington's disease mutation. The sensitivity and specificity of measuring CAG repeats. N Engl J Med. 1994; 330(20):1401-6. DOI: 10.1056/NEJM199405193302001. View

13.

Semaka A, Creighton S, Warby S, Hayden M . Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet. 2006; 70(4):283-94. DOI: 10.1111/j.1399-0004.2006.00668.x. View

14.

Day J, Schut L, Moseley M, Durand A, Ranum L . Spinocerebellar ataxia type 8: clinical features in a large family. Neurology. 2000; 55(5):649-57. DOI: 10.1212/wnl.55.5.649. View

15.

Vincent J, Yuan Q, Schalling M, Adolfsson R, Azevedo M, Macedo A . Long repeat tracts at SCA8 in major psychosis. Am J Med Genet. 2000; 96(6):873-6. DOI: 10.1002/1096-8628(20001204)96:6<873::aid-ajmg37>3.0.co;2-9. View

16.

Costa M, Teixeira-Castro A, Constante M, Magalhaes M, Magalhaes P, Cerqueira J . Exclusion of mutations in the PRNP, JPH3, TBP, ATN1, CREBBP, POU3F2 and FTL genes as a cause of disease in Portuguese patients with a Huntington-like phenotype. J Hum Genet. 2006; 51(8):645-651. PMC: 2909272. DOI: 10.1007/s10038-006-0001-9. View

17.

Margolis R, Holmes S, Rosenblatt A, Gourley L, OHearn E, Ross C . Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol. 2004; 56(5):670-4. DOI: 10.1002/ana.20248. View

18.

Munhoz R, Teive H, Raskin S, Werneck L . CTA/CTG expansions at the SCA 8 locus in multiple system atrophy. Clin Neurol Neurosurg. 2008; 111(2):208-10. DOI: 10.1016/j.clineuro.2008.09.003. View

19.

Moseley M, Zu T, Ikeda Y, Gao W, Mosemiller A, Daughters R . Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet. 2006; 38(7):758-69. DOI: 10.1038/ng1827. View

20.

Worth P, Houlden H, Giunti P, Davis M, Wood N . Large, expanded repeats in SCA8 are not confined to patients with cerebellar ataxia. Nat Genet. 2000; 24(3):214-5. DOI: 10.1038/73411. View